Prednisone: Various Uses For Cancer Patients

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that relieves swelling on various parts of the body. It also helps with nausea experienced by chemo patients. It can prevent allergic reactions.

The terms "Hodgkin's lymphoma" and "Hodgkin lymphoma" are used interchangeably on this site

It is used in conjunction with the treatment of many types of cancers, including both Hodgkin and Non-Hodgkin lymphoma. It is almost always given in combination with chemotherapy agents, and plays a part in these regimens:

  • BEACOPP (bleomycin, etoposide, adriamycin, cytoxan, oncovin, prednisone, procarbazine)
  • CHOP (cytoxan, adriamycin, oncovin, prednisone)
  • The CHOP regimen is also being studied in combination with the Zevalin® regimen for certain types of B-cell lymphomas.
  • MOPP (mustargen, oncovin, procarbazine, prednisone)
  • ChIVPP/EVA (chlorambucil, oncovin, procarbazine, prenisone, etoposide, vinblastine, adriamycin)
  • COPP (cytoxan, oncovin, procarbazine, prednisone)
  • Stanford-V (adriamycin, mustargen, bleomycin, vinblastine, oncovin, etoposide, prednisone)

Drug Administration

Prednisone is taken as a pill once a day either at meals or after eating.

Side Effects

Common side effects include weight gain, increased appetite, insomnia (difficulty sleeping), swelling due to water retention, slow healing, increased blood sugar, nausea, and heartburn.

Less common side effects include headaches, mood swings, dizziness, and bone thinning. Bone thinning can lead to osteonecrosis, or the depletion of bone at the joints, especially in the hips. For patients on prednisone for long periods of time, bone scans should be conducted regularly.

Prednisone makes you more susceptible to illness and can mask infections; stay away from people who are sick.

For more information on Hodgkin's Lymphoma, please see the following pages:

For more information on Non-Hodgkin's Lymphoma, please see the following pages:

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap